The total return over the past 12 months is -98.04% vs. +16.94% for the S&P 500. So far it's up -94.39% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (98.04%) | (91.13%) | N/A | N/A | N/A | N/A |
| Total Return CAGR | (98.04%) | (91.13%) | N/A | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Aspire Biopharma Holdings, Inc. (ASBP)
| Year | Start price | End price | ASBP Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $158.40 | $8.88 | (94.39%) | +14.51% | (108.90%) |
| 2025 | $13,800.00 | $158.40 | (98.85%) | +17.72% | (116.57%) |
| 2024 | $13,068.00 | $13,800.00 | +5.60% | +24.89% | (19.29%) |
| 2023 | $12,360.00 | $13,068.00 | +5.73% | +26.19% | (20.46%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
